Lixte Biotechnology Holdings, Inc. (LIXT)
NASDAQ: LIXT · Real-Time Price · USD
1.270
0.00 (-0.01%)
Feb 24, 2025, 11:51 AM EST - Market open
LIXT Employees
As of December 31, 2023, Lixte Biotechnology Holdings had 4 total employees, including 3 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
4
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,000,132
Market Cap
2.86M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
LIXT News
- 11 days ago - LIXTE Biotechnology Announces Closing of $1.05 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire
- 13 days ago - LIXTE Biotechnology Announces $1.05 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire
- 13 days ago - LIXTE Biotechnology Submits Request for Withdrawal of Form S-1 Registration Statement - GlobeNewsWire
- 6 months ago - LIXTE Receives U.S. Patent Issue Notification for Immune Oncology - GlobeNewsWire
- 6 months ago - First Patient Dosed with LIXTE's LB-100 in New Clinical Trial to Treat Colorectal Cancer, Collaborating with NKI, Supported by Major Pharma Company - GlobeNewsWire
- 6 months ago - LIXTE Biotechnology Provides Update On Recent Activities and Developments - GlobeNewsWire
- 6 months ago - LIXTE Biotechnology Holdings to Present at Two Investor Conferences - GlobeNewsWire
- 6 months ago - Lixte Biotechnology Holdings, Inc. to Present at August 20th Virtual Investor Summit Microcap Event - Accesswire